Login to Your Account



Other News To Note


Thursday, April 5, 2012

• Cytos Biotechnology Ltd., of Zurich, Switzerland, said the Swiss Takeover Board approved an exemption allowing the investors in its CHF37 million (US$40.6 million) recapitalization to hold more than one-third of the company's outstanding shares when the financing closes.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription